Kenji Shibuya
Overview
Explore the profile of Kenji Shibuya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
229
Citations
37944
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ejima K, Ajelli M, Singh A, Chua H, Ponce L, Wang Y, et al.
Commun Med (Lond)
. 2025 Mar;
5(1):76.
PMID: 40082681
Background: In the absence of effective pharmaceutical interventions early in an infectious disease outbreak, non-pharmaceutical measures, especially isolating infected individuals, critically limit its impact. The ongoing COVID-19 pandemic has sparked...
2.
Sithu Shein A, Hongsing P, Khatib A, Phattharapornjaroen P, Miyanaga K, Cui L, et al.
NPJ Antimicrob Resist
. 2025 Jan;
2(1):31.
PMID: 39843534
Persistent bacterial lung infections in children lead to significant morbidity and mortality due to antibiotic resistance. In this paper, we describe how phage therapy has shown remarkable efficacy in preclinical...
3.
Takamatsu A, Honda H, Miwa T, Tabuchi T, Taniguchi K, Shibuya K, et al.
Asia Pac J Public Health
. 2024 Dec;
37(1):108-115.
PMID: 39688023
Few longitudinal studies have examined the impact of the COVID-19 pandemic on personal behaviors. This study investigated changes in four social behaviors among the Japanese public during and after the...
4.
Miwa T, Honda H, Takamatsu A, Tabuchi T, Taniguchi K, Shibuya K, et al.
J Public Health (Oxf)
. 2024 Oct;
47(1):e1-e10.
PMID: 39385666
Background: The present study aimed to investigate the association between the duration of anti-coronavirus disease 2019 (COVID-19) public health measures and the quality of life (QOL) and mental health of...
5.
Wannigama D, Amarasiri M, Phattharapornjaroen P, Hurst C, Modchang C, Besa J, et al.
Lancet Infect Dis
. 2024 Aug;
24(10):e610-e613.
PMID: 39181146
No abstract available.
6.
Nakamura N, Kobashi Y, Kim K, Park H, Tani Y, Shimazu Y, et al.
PLOS Digit Health
. 2024 May;
3(5):e0000497.
PMID: 38701055
As we learned during the COVID-19 pandemic, vaccines are one of the most important tools in infectious disease control. To date, an unprecedentedly large volume of high-quality data on COVID-19...
7.
Honda H, Takamatsu A, Miwa T, Tabuchi T, Nakamura H, Taniguchi K, et al.
Asia Pac J Public Health
. 2024 Apr;
36(4):366-377.
PMID: 38600739
During the COVID-19 pandemic, people often modified their behaviors and performed individual infection control practices despite the uncertain effectiveness of these in preventing COVID-19. A cross-sectional study using a nationwide...
8.
Wannigama D, Amarasiri M, Phattharapornjaroen P, Hurst C, Modchang C, Chadsuthi S, et al.
Lancet Infect Dis
. 2024 Mar;
24(6):e348-e350.
PMID: 38522445
No abstract available.
9.
Wannigama D, Amarasiri M, Phattharapornjaroen P, Hurst C, Modchang C, Chadsuthi S, et al.
J Travel Med
. 2024 Mar;
31(4).
PMID: 38438141
No abstract available.
10.
Anupong S, Chadsuthi S, Hongsing P, Hurst C, Phattharapornjaroen P, Rad S M A, et al.
iScience
. 2024 Feb;
27(3):109043.
PMID: 38375225
This study investigated the potential of using SARS-CoV-2 viral concentrations in dust as an additional surveillance tool for early detection and monitoring of COVID-19 transmission. Dust samples were collected from...